1. Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
- Author
-
Boldizsar Kovacs, Michael Mayinger, Nicolaus Andratschke, Ardan M Saguner, and University of Zurich
- Subjects
Catheter Ablation ,Tachycardia, Ventricular ,10209 Clinic for Cardiology ,Humans ,Arrhythmias, Cardiac ,610 Medicine & health ,STAR, radioablation, cardiology, radiation oncology ,Cardiology and Cardiovascular Medicine ,10044 Clinic for Radiation Oncology ,2705 Cardiology and Cardiovascular Medicine - Abstract
Cardiology and Radiation Oncology working together—a new ‘STAR’ on the horizon? Until recently, most cardiologists associated radiation exposure to the heart with potential adverse effects, such as pericarditis, late coronary artery disease or potential damage to cardiac implantable devices. The landmark publication of 2017 reporting a case series of just five patients with recurrent ventricular tachycardia (VT) treated with stereotactic arrhythmia radioablation (STAR) changed this perception and introduced a new area for both cardiac electrophysiology and radiation oncology.
- Published
- 2022